PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Strengthens Commercial Momentum Ahead Of CEO Transition

Robust procedure growth and expanding consumables sales support a constructive near-term profile despite negative profitability metrics. Management changes and upgraded guidance create a clear set of near-term catalysts for market attention.

Recent News

On July 24, 2025 the company announced Larry L. Wood will become president and CEO effective September 2, 2025, with Dr. Reza Zadno retiring September 1, 2025; the release also pre-announced second-quarter 2025 revenue of approximately $79.2 million. On August 6, 2025 the company reported second-quarter 2025 results, disclosing $79.2 million in revenue (up 48% year-over-year), 51 U.S. robotic systems sold in the quarter, international revenue growth of 69%, and an upward revision to fiscal 2025 revenue guidance to $325.5 million.

Technical Analysis

Directional Indicators (ADX / DI+ / DI-): ADX at 22.61 signals an emerging trend in strength rather than a strong, sustained trend; DI+ experienced a peak-and-reversal, which reads as bearish, while DI- is decreasing and therefore reads as bullish. The combination implies short-term conflict between upside momentum and recent selling pressure, producing a mixed but narrowing technical bias toward stabilization.

MACD: MACD stands at -1.99 with the MACD line above its signal (-2.38), and the MACD trend shows increasing momentum; that cross above the signal line constitutes a bullish momentum signal despite the negative absolute MACD value.

MRO: MRO sits at -3.94 with a dip-and-reversal pattern; negative MRO indicates price below model target and therefore potential upside pressure, while the dip-and-reversal points toward a developing bullish corrective phase relative to that target.

RSI: RSI at 38.23 with a dip-and-reversal pattern indicates momentum recovering from a recent pullback and leaves room for upward movement before reaching overbought territory.

Price Versus Moving Averages & Bollinger: Last close $38.03 crossed above the -1x standard-deviation Bollinger band, signaling a short-term lift from oversold levels. Price sits just under the 20-day average ($38.66) and well below the 50-day ($45.56) and 200-day ($60.85), which frames near-term upside targets at the short-term moving averages while longer-term averages remain out of reach absent sustained follow-through.

Ichimoku & Support/Resistance: Chikou span below the Ichimoku cloud and Senkou lines (Senkou A $49.24 / Senkou B $51.98) highlight longer-term bearish pressure; the super trend upper at $42.41 provides immediate resistance above current price.

Volume & Volatility: Daily volume (~874k) trades below the 10-day average (~1.08M), suggesting lower conviction on recent price moves. Volatility measures (42-day and 52-week) remain muted at 0.04, indicating tighter ranges for swing setups.

 


Fundamental Analysis

Revenue & Growth: Total revenue $79,182,000 for the period. YoY revenue growth registers at -26.79% while an alternative growth metric registers 14.49%; quarter-over-quarter revenue growth shows a large positive move of 967.65% in the supplied QoQ field. The company reported strong consumable and system revenue in recent quarters, reflected in sequential and annual top-line strength reported by management.

Margins & Profitability: Gross margin stands at 65.35%. Operating margin at -28.02% and EBIT margin at -23.60% reflect ongoing operating losses; EBIT margin contracted QoQ by -31.61% and YoY by -48.82%. EBIT margin compares unfavorably with the industry peer mean of 18.59% and industry peer median of 17.48%.

Earnings Per Share: Reported EPS at -$0.35 versus an estimate of -$0.41, producing an EPS surprise ratio of +14.63%, which signals a smaller-than-expected per-share loss for the reported period.

Cash, Liquidity & Capital Structure: Cash and short-term investments total $302,717,000 with a cash ratio of 6.09 and current ratio of 9.21, indicating substantial near-term liquidity relative to liabilities. Total debt sits at $79,367,000 with debt-to-equity of 0.206. Operating cash flow reads -$15,043,000 and free cash flow -$17,845,000, yielding a free cash flow yield of -0.65%.

Efficiency & Returns: Asset turnover at 0.153 reflects modest revenue generation from assets and sits above the industry peer mean of 0.121. Return on equity at -5.08% and return on assets at -3.79% remain negative, driven by operating losses.

Valuation: Price-to-book at 7.12 sits slightly above the industry peer mean of 6.29 and median of 6.87. Price-to-sales at 34.70 remains elevated versus a peer mean of 32.43. Forward metrics remain negative for earnings-based multiples. The current valuation as determined by WMDST registers as under-valued given the combination of cash resources, procedural momentum, and growth outlook, despite ongoing negative profitability and elevated market multiples.

MOST-RECENT QUARTERLY REPORT
REPORT PERIOD ENDING: 2025-06-30
REPORT DATE: 2025-08-06
NEXT REPORT DATE: 2025-10-23
CASH FLOW  Begin Period Cash Flow 319.2 M
 Operating Cash Flow -15.04 M
 Capital Expenditures -2.80 M
 Change In Working Capital -9.50 M
 Dividends Paid
 Cash Flow Delta -13.49 M
 End Period Cash Flow 305.8 M
 
INCOME STATEMENT REVENUE
 Total Revenue 79.2 M
 Forward Revenue 18.7 M
COSTS
 Cost Of Revenue 27.4 M
 Depreciation 1.6 M
 Depreciation and Amortization 1.6 M
 Research and Development 17.6 M
 Total Operating Expenses 101.4 M
PROFITABILITY
 Gross Profit 51.7 M
 EBITDA -17.09 M
 EBIT -18.68 M
 Operating Income -22.19 M
 Interest Income 3.5 M
 Interest Expense 895.0 K
 Net Interest Income 2.6 M
 Income Before Tax -19.58 M
 Tax Provision
 Tax Rate
 Net Income -19.58 M
 Net Income From Continuing Operations -19.58 M
EARNINGS
 EPS Estimate -0.41
 EPS Actual -0.35
 EPS Difference 0.06
 EPS Surprise 14.634 %
 Forward EPS -0.33
 
BALANCE SHEET ASSETS
 Total Assets 513.1 M
 Intangible Assets 795.0 K
 Net Tangible Assets 385.0 M
 Total Current Assets 458.1 M
 Cash and Short-Term Investments 302.7 M
 Cash 302.7 M
 Net Receivables 80.8 M
 Inventory 67.0 M
 Long-Term Investments 7.3 M
LIABILITIES
 Accounts Payable 11.8 M
 Short-Term Debt
 Total Current Liabilities 49.7 M
 Net Debt
 Total Debt 79.4 M
 Total Liabilities 127.3 M
EQUITY
 Total Equity 385.8 M
 Retained Earnings -590.30 M
VALUATION & PER-SHARE METRICS EQUITY & PER-SHARE METRICS
 Book Value Per-Share 6.94
 Shares Outstanding 55.577 M
 Revenue Per-Share 1.42
VALUATION
 Market Capitalization 2.7 B
 Enterprise Value 2.5 B
 Enterprise Multiple -147.649
Enterprise Multiple QoQ 4.967 %
Enterprise Multiple YoY 13.106 %
Enterprise Multiple IPRWA high: 123.29
median: 110.415
mean: 94.983
low: -124.374
PRCT: -147.649
 EV/R 31.877
CAPITAL STRUCTURE
 Asset To Equity 1.33
 Asset To Liability 4.032
 Debt To Capital 0.171
 Debt To Assets 0.155
Debt To Assets QoQ -1.79 %
Debt To Assets YoY 3170.613 %
Debt To Assets IPRWA high: 0.843
mean: 0.299
median: 0.292
PRCT: 0.155
low: 0.0
 Debt To Equity 0.206
Debt To Equity QoQ -2.145 %
Debt To Equity YoY 2826.316 %
Debt To Equity IPRWA high: 3.369
mean: 0.632
median: 0.579
PRCT: 0.206
low: -0.395
PRICE-BASED VALUATION
 Price To Book (P/B) 7.121
Price To Book QoQ -18.084 %
Price To Book YoY -44.956 %
Price To Book IPRWA high: 16.759
PRCT: 7.121
median: 6.869
mean: 6.286
low: -5.981
 Price To Earnings (P/E) -163.125
Price To Earnings QoQ 18.726 %
Price To Earnings YoY 29.952 %
Price To Earnings IPRWA high: 249.6
mean: 137.468
median: 121.658
PRCT: -163.125
low: -167.592
 PE/G Ratio 7.341
 Price To Sales (P/S) 34.697
Price To Sales QoQ -29.067 %
Price To Sales YoY -43.17 %
Price To Sales IPRWA high: 73.117
PRCT: 34.697
mean: 32.427
median: 24.499
low: 0.6
FORWARD MULTIPLES
Forward P/E -178.419
Forward PE/G 8.029
Forward P/S 147.041
EFFICIENCY OPERATIONAL
 Operating Leverage -1.498
ASSET & SALES
 Asset Turnover Ratio 0.153
Asset Turnover Ratio QoQ 16.815 %
Asset Turnover Ratio YoY 8.857 %
Asset Turnover Ratio IPRWA high: 0.412
PRCT: 0.153
median: 0.124
mean: 0.121
low: 0.008
 Receivables Turnover 0.989
Receivables Turnover Ratio QoQ 16.404 %
Receivables Turnover Ratio YoY 6.614 %
Receivables Turnover Ratio IPRWA high: 3.133
mean: 1.737
median: 1.672
PRCT: 0.989
low: 0.374
 Inventory Turnover 0.424
Inventory Turnover Ratio QoQ 0.524 %
Inventory Turnover Ratio YoY -17.102 %
Inventory Turnover Ratio IPRWA high: 2.014
mean: 0.649
median: 0.568
PRCT: 0.424
low: 0.084
 Days Sales Outstanding (DSO) 92.241
CASH CYCLE
 Cash Conversion Cycle Days (CCC) 279.756
Cash Conversion Cycle Days QoQ -0.548 %
Cash Conversion Cycle Days YoY 11.259 %
Cash Conversion Cycle Days IPRWA high: 448.876
PRCT: 279.756
mean: 170.619
median: 167.784
low: -175.55
CAPITAL DEPLOYMENT
 Cash Conversion Ratio 0.194
 CapEx To Revenue -0.035
 CapEx To Depreciation -1.764
 
CAPITAL, LIQUIDITY & COVERAGE CAPITAL STRUCTURE
 Total Capital 437.3 M
 Net Invested Capital 437.3 M
 Invested Capital 437.3 M
 Net Tangible Assets 385.0 M
 Net Working Capital 408.3 M
LIQUIDITY
 Cash Ratio 6.088
 Current Ratio 9.212
Current Ratio QoQ 2.964 %
Current Ratio YoY 22.61 %
Current Ratio IPRWA high: 13.958
PRCT: 9.212
mean: 2.526
median: 1.718
low: 0.027
 Quick Ratio 7.864
Quick Ratio QoQ 1.475 %
Quick Ratio YoY 21.182 %
Quick Ratio IPRWA high: 12.697
PRCT: 7.864
mean: 1.862
median: 1.167
low: 0.315
COVERAGE & LEVERAGE
 Debt To EBITDA -4.643
 Cost Of Debt 1.04 %
 Interest Coverage Ratio -20.875
Interest Coverage Ratio QoQ -23.272 %
Interest Coverage Ratio YoY -12.583 %
Interest Coverage Ratio IPRWA high: 52.298
mean: 15.574
median: 11.456
PRCT: -20.875
low: -88.481
 Operating Cash Flow Ratio -0.549
TIMING / LIQUIDITY
 Days Payables Outstanding (DPO) 48.561
DIVIDENDS
 Dividend Coverage Ratio
 Dividend Payout Ratio
 Dividend Rate
 Dividend Yield
PERFORMANCE GROWTH
 Asset Growth Rate -1.217 %
 Revenue Growth 14.488 %
Revenue Growth QoQ 967.649 %
Revenue Growth YoY -26.788 %
Revenue Growth IPRWA high: 26.158 %
PRCT: 14.488 %
median: 7.833 %
mean: 6.291 %
low: -39.052 %
 Earnings Growth -22.222 %
Earnings Growth QoQ -177.778 %
Earnings Growth YoY 1033.197 %
Earnings Growth IPRWA high: 166.667 %
mean: 11.437 %
median: 9.851 %
PRCT: -22.222 %
low: -180.612 %
MARGINS
 Gross Margin 65.351 %
Gross Margin QoQ 2.348 %
Gross Margin YoY 10.751 %
Gross Margin IPRWA high: 91.006 %
PRCT: 65.351 %
median: 63.683 %
mean: 62.179 %
low: -7.085 %
 EBIT Margin -23.595 %
EBIT Margin QoQ -31.607 %
EBIT Margin YoY -48.819 %
EBIT Margin IPRWA high: 33.709 %
mean: 18.594 %
median: 17.478 %
PRCT: -23.595 %
low: -200.872 %
 Return On Sales (ROS) -28.023 %
Return On Sales QoQ -18.772 %
Return On Sales YoY -39.214 %
Return On Sales IPRWA high: 39.857 %
mean: 19.123 %
median: 18.374 %
PRCT: -28.023 %
low: -193.243 %
CASH FLOW
 Free Cash Flow (FCF) -17.84 M
 Free Cash Flow Yield -0.65 %
Free Cash Flow Yield QoQ 16.906 %
Free Cash Flow Yield YoY 26.214 %
Free Cash Flow Yield IPRWA high: 4.685 %
median: 0.712 %
mean: 0.68 %
PRCT: -0.65 %
low: -19.501 %
 Free Cash Growth -5.161 %
Free Cash Growth QoQ -88.255 %
Free Cash Growth YoY -89.877 %
Free Cash Growth IPRWA high: 310.383 %
mean: 85.817 %
median: 14.619 %
PRCT: -5.161 %
low: -376.098 %
 Free Cash To Net Income 0.911
 Cash Flow Margin -34.46 %
 Cash Flow To Earnings 1.394
VALUE & RETURNS
 Economic Value Added
 Return On Assets (ROA) -3.793 %
Return On Assets QoQ -19.246 %
Return On Assets YoY -43.957 %
Return On Assets IPRWA high: 16.404 %
mean: 1.764 %
median: 1.686 %
PRCT: -3.793 %
low: -26.44 %
 Return On Capital Employed (ROCE) -4.032 %
 Return On Equity (ROE) -0.051
Return On Equity QoQ -20.167 %
Return On Equity YoY -50.138 %
Return On Equity IPRWA high: 0.175
median: 0.032
mean: 0.029
PRCT: -0.051
low: -0.524
 DuPont ROE -5.053 %
 Return On Invested Capital (ROIC)
Return On Invested Capital QoQ
Return On Invested Capital YoY
Return On Invested Capital IPRWA

Six-Week Outlook

Near-term technical cues favor a stabilization and measured rebound. Bullish momentum from the MACD cross and dip-and-reversal patterns in MRO and RSI point to possible upside toward the 20-day average ($38.66) and initial resistance near the super trend upper ($42.41). The ADX level signals an emerging trend rather than a strong directional move, so expect any advance to encounter resistance at the 50-day average ($45.56) and Ichimoku Senkou lines unless volume and volatility increase. Fundamental drivers to watch include consumables and system revenue cadence, progress on clinical enrollment updates, and the transition in executive leadership; those items will determine whether the current technical lift gains conviction or reverts to the prevailing longer-term downtrend defined by the 200-day average.

About PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) develops innovative surgical robotics solutions targeting urological conditions. Headquartered in San Jose, California, the company manufactures and markets the AquaBeam Robotic System, an advanced image-guided robotic platform designed for minimally invasive urologic surgeries. This system primarily addresses benign prostatic hyperplasia (BPH), a common condition affecting the prostate in men. By integrating Aquablation therapy, PROCEPT BioRobotics offers a precise and effective treatment for males experiencing lower urinary tract symptoms due to BPH. Established in 2007, the company extends its reach both domestically and internationally, striving to enhance surgical outcomes and improve patient care in the field of urology.



© 2025 WMDST — The World’s Most Dangerous Swing Trader. All rights reserved.